Insider · CIK 0001944011

Carter Todd Alfred

Reports to the SEC for 1 company · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001944011

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-24	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,174 sh	$3.76	−$15.7K	145,718
2026-02-18	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,301 sh	$3.44	−$11.4K	149,892
2026-02-10	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,525 sh	$3.85	−$13.6K	153,193
2026-02-06	VYGRVoyager Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+33K sh	—	—	156,718
2026-02-06	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+154K sh	—	—	154,000
2025-02-21	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+92K sh	—	—	92,000
2025-02-21	VYGRVoyager Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+46K sh	—	—	123,718
2025-02-20	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,305 sh	$4.26	−$14.1K	77,718
2025-02-11	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,413 sh	$4.45	−$24.1K	81,023
2025-01-14	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,191 sh	$5.13	−$6,109.83	86,436
2024-02-21	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,365 sh	$7.47	−$25.1K	87,627
2024-02-20	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−602 sh	$7.68	−$4,623.36	90,992
2024-02-09	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+77K sh	—	—	77,000
2024-02-09	VYGRVoyager Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+38.5K sh	—	—	91,594
2024-01-17	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,266 sh	$7.18	−$9,089.88	53,094
2023-09-15	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10.5K sh	$8.16	−$85.7K	54,360
2023-09-15	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,000 sh	—	—	40,000
2023-09-15	VYGRVoyager Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$2.85	+$14.3K	64,860
2023-07-06	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,500 sh	$10.80	−$59.4K	59,860
2023-06-30	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,000 sh	—	—	45,000
2023-06-30	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$11.41	−$57.1K	65,360
2023-06-30	VYGRVoyager Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$2.85	+$14.3K	70,360
2023-03-20	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,193 sh	$7.76	−$17K	65,360
2023-02-17	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−738 sh	$7.45	−$5,498.1	67,553
2023-02-17	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+68K sh	—	—	68,000
2023-02-17	VYGRVoyager Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+34K sh	—	—	68,291
2023-02-13	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−797 sh	$7.67	−$6,112.99	34,291
2023-01-17	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−706 sh	$9.57	−$6,756.42	35,488
2023-01-17	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−400 sh	$10.34	−$4,136	35,088
2023-01-06	VYGRVoyager Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−388 sh	$6.41	−$2,487.08	36,194
2022-12-31	VYGRVoyager Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+388 sh	$5.17	+$2,005.96	36,582
2022-09-19	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+165K sh	—	—	165,000

Recent filings

Accepted (ET)
Feb 264
Carter Todd Alfred0001104659-26-020176
SEC(opens sec.gov)
Feb 204
Carter Todd Alfred0001104659-26-018130
SEC(opens sec.gov)
Feb 114
Carter Todd Alfred0001104659-26-013408
SEC(opens sec.gov)
Feb 104
Carter Todd Alfred0001104659-26-012677
SEC(opens sec.gov)
Feb 244
Carter Todd Alfred0001104659-25-016522
SEC(opens sec.gov)
Feb 124
Carter Todd Alfred0001104659-25-012200
SEC(opens sec.gov)
Jan 154
Carter Todd Alfred0001104659-25-003772
SEC(opens sec.gov)
Feb 224
Carter Todd Alfred0001104659-24-026554
SEC(opens sec.gov)
Feb 164
Carter Todd Alfred0001104659-24-024993
SEC(opens sec.gov)
Jan 194
Carter Todd Alfred0001104659-24-005244
SEC(opens sec.gov)
Sep 184
Carter Todd Alfred0001104659-23-101631
SEC(opens sec.gov)
Jul 104
Carter Todd Alfred0001104659-23-079686
SEC(opens sec.gov)
Jul 54
Carter Todd Alfred0001104659-23-078152
SEC(opens sec.gov)

Companies

Voyager Therapeutics, Inc.Chief Scientific OfficerVYGR

Address

C/O VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE

LEXINGTON, MA, 02421